• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
First-degree relatives of patients with type 2 diabetes mellitus and risk of non-alcoholic Fatty liver disease.2型糖尿病患者的一级亲属与非酒精性脂肪性肝病风险
Rev Diabet Stud. 2007 Winter;4(4):236-41. doi: 10.1900/RDS.2007.4.236. Epub 2008 Feb 10.
2
The influence of insulin resistance in the occurence of non-alcoholic fatty liver disease among first degree relatives of type 2 diabetes.胰岛素抵抗对2型糖尿病一级亲属中非酒精性脂肪性肝病发生的影响。
Diabetes Metab Syndr. 2019 Mar-Apr;13(2):1431-1435. doi: 10.1016/j.dsx.2019.01.058. Epub 2019 Jan 31.
3
Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus.肥胖与非酒精性脂肪性肝病对2型糖尿病发病率影响的比较。
World J Gastroenterol. 2015 Aug 28;21(32):9607-13. doi: 10.3748/wjg.v21.i32.9607.
4
IMPACT OF TYPE 2 DIABETES ON NONALCOHOLIC STEATOHEPATITIS AND ADVANCED FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE.2 型糖尿病对非酒精性脂肪性肝病患者非酒精性脂肪性肝炎和肝纤维化进展的影响。
Endocr Pract. 2020 Apr;26(4):444-453. doi: 10.4158/EP-2019-0342. Epub 2020 Jan 22.
5
Association between resistin +299A/A genotype and nonalcoholic fatty liver disease in Chinese patients with type 2 diabetes mellitus.中国人 2 型糖尿病患者抵抗素+299A/A 基因型与非酒精性脂肪性肝病的关系。
Gene. 2013 Oct 25;529(2):340-4. doi: 10.1016/j.gene.2013.08.001. Epub 2013 Aug 14.
6
Serum phospholipid omega-3 polyunsaturated fatty acids and insulin resistance in type 2 diabetes mellitus and non-alcoholic fatty liver disease.2型糖尿病和非酒精性脂肪性肝病患者血清磷脂ω-3多不饱和脂肪酸与胰岛素抵抗
J Diabetes Complications. 2014 Sep-Oct;28(5):711-4. doi: 10.1016/j.jdiacomp.2014.04.008. Epub 2014 Apr 18.
7
Profile of liver enzymes in non-alcoholic fatty liver disease in patients with impaired glucose tolerance and newly detected untreated type 2 diabetes.糖耐量受损和新诊断未治疗的2型糖尿病患者非酒精性脂肪性肝病中的肝酶谱
Indian J Endocrinol Metab. 2015 Sep-Oct;19(5):597-601. doi: 10.4103/2230-8210.163172.
8
Elevated Liver Enzymes in Patients with Type 2 Diabetes Mellitus and Non-alcoholic Fatty Liver Disease.2型糖尿病合并非酒精性脂肪性肝病患者的肝酶升高
Cureus. 2018 Nov 23;10(11):e3626. doi: 10.7759/cureus.3626.
9
[Non-alcoholic fatty liver disease increases the incidence rate of type 2 diabetes mellitus: a cohort study based on a rural town elderly population of southern Jiangsu].[非酒精性脂肪性肝病增加2型糖尿病发病率:一项基于苏南某乡镇老年人群的队列研究]
Zhonghua Gan Zang Bing Za Zhi. 2021 Sep 20;29(9):867-872. doi: 10.3760/cma.j.cn501113-20200429-00223.
10
Histopathological differences utilizing the nonalcoholic fatty liver disease activity score criteria in diabetic (type 2 diabetes mellitus) and non-diabetic patients with nonalcoholic fatty liver disease.利用非酒精性脂肪性肝病活动评分标准对糖尿病(2型糖尿病)和非糖尿病非酒精性脂肪性肝病患者进行组织病理学差异分析。
World J Hepatol. 2015 Nov 8;7(25):2610-8. doi: 10.4254/wjh.v7.i25.2610.

引用本文的文献

1
Parental History of Type 2 Diabetes Mellitus and PNPLA3 Polymorphism Increase the Risk of Severe Stages of Nonalcoholic Fatty Liver Disease.2型糖尿病家族史和PNPLA3基因多态性增加非酒精性脂肪性肝病严重阶段的风险。
Dig Dis Sci. 2024 Feb;69(2):634-642. doi: 10.1007/s10620-023-08214-7. Epub 2023 Dec 19.
2
Non-alcoholic fatty liver disease and the impact of genetic, epigenetic and environmental factors in the offspring.非酒精性脂肪性肝病及其遗传、表观遗传和环境因素对子代的影响。
World J Gastroenterol. 2022 Jul 7;28(25):2890-2899. doi: 10.3748/wjg.v28.i25.2890.
3
Safety, tolerability and pharmacodynamics of apical sodium-dependent bile acid transporter inhibition with volixibat in healthy adults and patients with type 2 diabetes mellitus: a randomised placebo-controlled trial.在健康成年人和2型糖尿病患者中使用volixibat抑制顶端钠依赖性胆汁酸转运体的安全性、耐受性和药效学:一项随机安慰剂对照试验
BMC Gastroenterol. 2018 Jan 5;18(1):3. doi: 10.1186/s12876-017-0736-0.
4
Comparative study of serum 8-hydroxydeoxy-guanosine levels among healthy offspring of diabetic and non-diabetic parents.糖尿病和非糖尿病父母的健康后代血清8-羟基脱氧鸟苷水平的比较研究。
Int J Health Sci (Qassim). 2017 Jul-Sep;11(3):33-37.
5
Absorption, Distribution, Metabolism, and Excretion of [C]-Volixibat in Healthy Men: Phase 1 Open-Label Study.健康男性中[C]-伏立昔布的吸收、分布、代谢及排泄:1期开放标签研究
Eur J Drug Metab Pharmacokinet. 2018 Feb;43(1):91-101. doi: 10.1007/s13318-017-0429-7.
6
Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis.糖尿病、糖尿病家族史与非酒精性脂肪性肝炎和肝纤维化风险的关系。
Hepatology. 2012 Sep;56(3):943-51. doi: 10.1002/hep.25772. Epub 2012 Jul 26.
7
First multicenter study for risk factors for hepatocellular carcinoma development in North Africa.关于北非肝细胞癌发生风险因素的首个多中心研究。
World J Hepatol. 2011 Jan 27;3(1):24-30. doi: 10.4254/wjh.v3.i1.24.

本文引用的文献

1
First nationwide survey of prevalence of overweight, underweight, and abdominal obesity in Iranian adults.伊朗成年人超重、体重不足和腹型肥胖患病率的首次全国性调查。
Obesity (Silver Spring). 2007 Nov;15(11):2797-808. doi: 10.1038/oby.2007.332.
2
Increased prevalence of cardiovascular disease in Type 2 diabetic patients with non-alcoholic fatty liver disease.患有非酒精性脂肪性肝病的2型糖尿病患者心血管疾病患病率增加。
Diabet Med. 2006 Apr;23(4):403-9. doi: 10.1111/j.1464-5491.2006.01817.x.
3
Pathophysiology of nonalcoholic steatohepatitis.非酒精性脂肪性肝炎的病理生理学
J Clin Gastroenterol. 2006 Mar;40 Suppl 1:S17-29. doi: 10.1097/01.mcg.0000168645.86658.22.
4
Nonalcoholic steatohepatitis and the metabolic syndrome.非酒精性脂肪性肝炎与代谢综合征
Am J Med Sci. 2005 Dec;330(6):326-35. doi: 10.1097/00000441-200512000-00011.
5
Recent concepts in non-alcoholic fatty liver disease.非酒精性脂肪性肝病的最新概念
Diabet Med. 2005 Sep;22(9):1129-33. doi: 10.1111/j.1464-5491.2005.01748.x.
6
Phenotypic and genetic clustering of diabetes and metabolic syndrome in Chinese families with type 2 diabetes mellitus.2型糖尿病中国家系中糖尿病和代谢综合征的表型与基因聚类分析
Diabetes Metab Res Rev. 2006 Jan-Feb;22(1):46-52. doi: 10.1002/dmrr.577.
7
The natural history of nonalcoholic fatty liver disease: a population-based cohort study.非酒精性脂肪性肝病的自然史:一项基于人群的队列研究。
Gastroenterology. 2005 Jul;129(1):113-21. doi: 10.1053/j.gastro.2005.04.014.
8
Nonalcoholic fatty liver disease and the metabolic syndrome.非酒精性脂肪性肝病与代谢综合征
Curr Opin Lipidol. 2005 Aug;16(4):421-7. doi: 10.1097/01.mol.0000174153.53683.f2.
9
Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease.非酒精性脂肪性肝病中的内皮功能障碍与心血管风险概况
Hepatology. 2005 Aug;42(2):473-80. doi: 10.1002/hep.20781.
10
The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies.非酒精性脂肪性肝病的组织学病程:一项对103例接受序贯肝活检患者的纵向研究
J Hepatol. 2005 Jan;42(1):132-8. doi: 10.1016/j.jhep.2004.09.012.

2型糖尿病患者的一级亲属与非酒精性脂肪性肝病风险

First-degree relatives of patients with type 2 diabetes mellitus and risk of non-alcoholic Fatty liver disease.

作者信息

Adibi Atoosa, Janghorbani Mohsen, Shayganfar Sanaz, Amini Masoud

机构信息

Department of Radiology, Medical School, Isfahan University of Medical Sciences, Isfahan, Iran.

出版信息

Rev Diabet Stud. 2007 Winter;4(4):236-41. doi: 10.1900/RDS.2007.4.236. Epub 2008 Feb 10.

DOI:10.1900/RDS.2007.4.236
PMID:18338077
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2270409/
Abstract

AIMS

The aim of this study was to determine whether first-degree relatives (FDR) of patients with type 2 diabetes mellitus (T2DM) are at higher risk of non-alcoholic fatty liver disease (NAFLD) than healthy controls.

METHODS

A total of 222 FDR of consecutive patients with T2DM aged between 35 and 55 years and 202 healthy individuals with no family history of diabetes were investigated for NAFLD. Fatty liver was diagnosed by ultrasonography using standard criteria. Height, weight, fasting glucose, alanine aminotransferase (ALT), total cholesterol and triglyceride were determined by routine laboratory methods.

RESULTS

Compared to subjects with no family history of diabetes, the age and sex adjusted odds ratio (OR) of NAFLD was 1.83 (95% CI: 1.11-3.03) for FDR of patients with T2DM. After further adjusting for BMI, fasting glucose, ALT, asparate aminotransferase (AST), triglyceride and cholesterol, the multivariate OR of prevalent NAFLD in FDR of patients with T2DM compared with individuals with no family history of diabetes was 1.56 (95% CI: 0.85-2.86).

CONCLUSIONS

The present study suggests that the relation between FDR of patients with T2DM and NAFLD is affected by the other covariates, in particular obesity, which points to a more complex relationship between the diseases. It appears that obesity and diabetes may independently predispose to NAFLD.

摘要

目的

本研究旨在确定2型糖尿病(T2DM)患者的一级亲属(FDR)患非酒精性脂肪性肝病(NAFLD)的风险是否高于健康对照者。

方法

对222名年龄在35至55岁之间的T2DM连续患者的FDR以及202名无糖尿病家族史的健康个体进行了NAFLD调查。采用标准标准通过超声诊断脂肪肝。通过常规实验室方法测定身高、体重、空腹血糖、丙氨酸氨基转移酶(ALT)、总胆固醇和甘油三酯。

结果

与无糖尿病家族史的受试者相比,T2DM患者FDR患NAFLD的年龄和性别调整优势比(OR)为1.83(95%CI:1.11 - 3.03)。在进一步调整BMI、空腹血糖、ALT、天冬氨酸氨基转移酶(AST)、甘油三酯和胆固醇后,T2DM患者FDR中NAFLD患病率与无糖尿病家族史个体相比的多变量OR为1.56(95%CI:0.85 - 2.86)。

结论

本研究表明,T2DM患者的FDR与NAFLD之间的关系受其他协变量影响,尤其是肥胖症,这表明两种疾病之间存在更复杂的关系。肥胖症和糖尿病似乎可能独立地易患NAFLD。